Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 6Polycystic Ovary Syndrome 5Obesity 5Motor Activity 3Ovarian Diseases 2Ovarian Cysts 2Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 2Feeding Behavior 2Cardiovascular Diseases 2Thyroid Neoplasms 1Thrombocythemia, Essential 1Smoldering Multiple Myeloma 1Primary Myelofibrosis 1Polycythemia Vera 1Overweight 1Neuroendocrine Tumors 1Myeloproliferative Disorders 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Monoclonal Gammopathy of Undetermined Significance 1Intermittent Fasting 1Inflammation 1Growth Hormone-Secreting Pituitary Adenoma 1Fibrosis 1Carcinoma, Hepatocellular 1

Interventions

lanreotide 1Temozolomide 1Surveys and Questionnaires 1Solutions 1Radiosurgery 1Microarray Analysis 1Injections 1Early Intervention, Educational 1Diet, Mediterranean 1Diet, Ketogenic 1DNA Methylation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Growth Hormone-Secreting Pituitary Adenoma × Diet, Mediterranean × Clear all
NCT06949891 2025-04-29

KETOACRO

Erasmus Medical Center

Phase NA Recruiting
60 enrolled
Endocrine

Growth Hormone-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡